Vagus nerve participates in regulation of the airways: Inflammatory response and hyperreactivity induced by occupational asthmogens

International Journal of Occupational Medicine and Environmental Health

Volumn 17, Issue 4, 2004, Pages 417-431

  Lutz, Waldemar ^a   Sułkowski, Wiesław J ^a  

^a NOFER INSTITUTE OF OCCUPATIONAL MEDICINE   (Poland)

Author keywords

Airway; Inflammation; Muscarinic acetylcholine receptors; Occupational asthmogens; Vagus nerve

Indexed keywords

ACETYLCHOLINE; ALLERGEN; IRRITANT AGENT; MUSCARINIC RECEPTOR; NEUROTRANSMITTER; OCCUPATIONAL ASTHMOGEN; UNCLASSIFIED DRUG;

AEROSOL; AIRWAY DYNAMICS; BRONCHUS HYPERREACTIVITY; CENTRAL NERVOUS SYSTEM; CHOLINERGIC NERVE; CHOLINERGIC SYSTEM; DENDRITIC CELL; DUST; EFFERENT NERVE; FUME; IMMUNOCOMPETENT CELL; INFLAMMATION; INNATE IMMUNITY; MACROPHAGE; OCCUPATIONAL ASTHMA; REVIEW; SENSORY NERVE; VAGUS NERVE;

EID: 13544270930     PISSN: 12321087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (94)

1. Lutz W, Pałczyński C. Advances in molecular immunotoxicology of occupational asthma induced by low molecular weight chemicals. Int J Occup Med Environ Health 2003; 16: 285-99.
2. Baker SF, Yin Y, Runswick SK, Stewart GA, Thompson PJ, Garrod DR, et al. Peptidase allergen Der p 1 initiates apoptosis of epithelial cells independently of tight junction proteolysis. Mol Membr Biol 2003; 20: 71-81.
3. Gallucci S, Matzinger P. Danger signals: SOS to the immune system. Curr Opin Immunol 2001; 13: 114-9.
4. Wan H, Winton HL, Soeller C, Tovey ER, Gruenert DC, Thompson PJ, et al. Der p 1 facilitates transepithelial allergen delivery by disruption of thigh junctions. J Clin Invest 1999; 104: 123-33.
5. Matzinger P. Tolerance, danger, and the extended family. Ann Rev Immunol 1994; 12: 991-1043.
6. Matzinger P. The danger model: A renewed sense of self. Science 2002; 296: 301-5.
7. Dantzer R, Konsman JP, Bluthe RM, Kelly KW. Neural and humoral pathways of communication from the immune system to the brain: parallel or convergent? Autonomic Neurosci Basic Clin 2000; 85: 60-5.
8. Goehler LE, Gaykema RPA, Hansen MK, Anderson K, Maier SF, Watkins LR. Vagal immune-to-brain communication: a visceral chemosensory pathway. Auton Neurosci Basic Clin 2000; 85: 49-59.
9. Hosoi T, Okuma Y, Nomura Y. The mechanisms of immune-to-brain communication in inflammation as a drug target. Curr Drug Targets Inflam Allergy 2002; 1: 257-62.
10. Elenkov IJ, Wilder RL, Chrousos GP, Vizi ES. The sympathetic nerve - An integrative interface between two supersystems: The brain and the immune system. Pharmacol Rev 2000; 52: 595-638.
11. Webster JI, Tonelli L, Sternberg EM. Neuroendocrine regulation of immunity. Annu Rev Immunol 2002; 20: 125-63.
12. Borovikova LV, Ivanova S, Zhang M, Yang H, Botchkina GI, Watkins LR, et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2000; 405: 458-62.
13. Tracey KJ. The inflammatory reflex. Nature 2002; 420: 853-9.
14. Barnes PJ. Neurogenic inflammation in the airways. Respir Physiol 2001; 125: 145-54.
15. Schachter SC. Vagus nerve stimulation: where we are? Curr Opin Neurol 2002; 15: 201-6.
16. Maddox L, Schwartz DA. The pathophysiology of asthma. Annu Rev Med 2002; 53: 477-98.
17. Fontan JJP. On lung nerves and neurogenic injury. Ann Med 2002; 34: 226-40.
18. Fontan JJP, Diec CT, Velloff CR. Bilateral distribution of vagal motor and sensory nerve fibers in the rat's lungs and airways. Am J Physiol 2000; 279: R713-28.
19. Fontan PJJ, Kinloch LP, Donnelly DF. Integration of bronchomotor and ventilatory responses to chemoreceptor stimulation in developing sheep. Respir Physiol 1998; 111: 1-13.
20. Richardson JB. Nerve supply to the lungs. Am Rev Resp Dis 1979; 119: 785-802.
21. Richardson CA, Herbert DA, Mitchell RA. Modulation of pulmonary stretch receptors and airway resistance by parasympathetic efferents. J Appl Physiol 1984; 57: 1842-9.
22. Li PC, Huang HT, Liang JT. Neurophysiological effects of recurrent laryngeal and thoracic vagus nerves on mediating the neurogenic inflammation of the trachea, bronchi, and esophagus of rats. Auton Neurosci 2001; 88: 142-50.
23. Coleridge HM, Coleridge JCG, Schultz HD. Afferent pathway involved in reflex regulation of airway smooth muscle. Pharmacol Ther 1989; 42: 421-63.
24. Hadziefendic S, Haxhiu MA. CNS innervation of vagal preganglionic neurons controlling peripheral airways: a transneuronal labeling study using pseudorabies virus. J Auton Nerv Syst 1999; 76: 135-45.
25. Solway J, Left AR. Sensory neuropeptides and airway functions. J Appl Physiol 1991; 71: 2077-87.
26. Lambrecht BN. Immunologists getting nervous: neuropeptides, dendritic cells and T cell activation. Respir Res 2001; 2: 133-8.
27. Wong SS, Sun NN, Keith I, Kweon Ch-B, Foster DE, Schauer JJ, et al. Tachykinin substance P signaling involved in diesel exhaust-induced bronchopulmonary neurogenic inflammation in rats. Arch Toxicol 2003; 77: 638-50.
28. Nathan C. Points of control in inflammation. Nature 2002; 420: 846-52.
29. Barnes PJ. Modulation of neurotransmission in airways. Physiol Rev 1992; 72: 699-729.
30. Barnes PJ. NANC nerves and neuropeptides. In: Barnes PJ, Rogres IW, Thomson NS, editors. Asthma: Basic Mechanism and Clinical Management. London: Academic Press; 1998. pp. 423-58.
31. Stout SC, Owens MJ, Nemeroff ChB. Neurokinin-1 receptor antagonists as potential antidepresants. Annu Rev Pharmacol Toxicol 2001; 41: 877-906.
32. Ho WZ, Lai JP, Zhu XH, Uvaydova M, Douglas SD. Human monocytes and macrophages express substance P and neurokinin-1 receptor. J Immunol 1997; 159: 5654-60.
33. Chavolla-Calderon M, Bayer MK, Fontan JJP. Bone marrow trasplantation reveals an essential synergy between neuronal and hemopoietic cell neurokinin production in pulmonary inflammation. J Clin Invest 2003; 111: 973-80.
34. Veronesi B, Oortgiesen M. Neurogenic inflammation and particulate matter (PM) air pollutants. Neurotoxicology 2001; 22: 795-810.
35. Lu-Yuan L, Widdicombe JG. Modulation of airway sensitivity to inhaled irritants: Role of inflammatory mediators. Environ Health Perspect 2001; 109(Suppl. 4): 585-9.
36. Long NC, Abraham J, Kobzik L, Weller EA, Krishna Murthy GG, Shore SA. Respiratory tract inflammation during the induction of chronic bronchitis in rats: role of C-fibers. Eur Respir J 1999; 14: 46-56.
37. 2) induces a decrease in calcitonin gene-related peptide (CGRP) and tachykinin immunoreactivity in guinea pig peripheral airways Eur Respir J 1996; 9: 1847-51.
38. 2 modulates the tetrodotoxin-resistant sodium current in neonatal rat dorsal root ganglion neurones via the cyclic AMP-protein kinase A cascade. J Physiol 1996; 495: 429-40.
39. Dery O, Corvera CU, Steinhoff M, Bunnett NW. Proteinase-activated receptors: novel mechanisms of signaling by serine proteases. Am J Physiol 1998; 274: C1429-52.
40. Steinhoff M, Vergnolle N, Young SH, Tognetto M, Amadesi S, Ennes HS, et al. Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism. Nature Med 2000; 6: 151-8.
41. Howarth PH, Djukanovic R, Wilson JW, Holgate ST, Springall DR, Polak JM. Mucosal nerves in endobronchial biopsies in asthma and non-asthma. Int Arch Allergy Appl Immunol 1991; 94: 330-3.
42. Lilly CM, Bai TR, Shore SA, Hall AE, Drazen JM. Neuropeptide content of lungs from asthmatic and nonasthmatic patients. Am J Respir Crit Care Med 1995; 151: 548-53.
43. Tomaki M, Ichinose M, Miura M. Elevated substance P content in induced sputum from patients with asthma and patients with chronic bronchitis. Am J Respir Crit Care Med 1995; 151: 613-7.
44. Czura ChJ, Friedman SG, Tracey KJ. Neural inhibition of inflammation: the cholinergic anti-inflammatory pathway. J Endotoxin Res 2003; 9: 409-13.
45. Wang N, Yu M, Ochani M, Amella CA, Tanovic M, Susarla S, et al. Nicotinic acetylcholine receptor a7 subunit is an essential regulator of inflammation. Nature 2003; 421: 384-8.
46. Tracey KJ. Supression of TNF and other proinflammatory cytokines in monocytes by a tetravalent guanylhydrazone CNI-1493. Prog Clin Biol Res 1998; 397: 927-36.
47. Tracey KJ, Czura CJ, Ivanova S. Mind over immunity. FASEB J 2001; 15: 1575-6.
48. Bernik TR, Friedman SG, Ochani M, DiRaimo R, Ulloa L, Yang H, et al. Pharmacological stimulation of the cholinergic antiinflammatory pathway. J Exp Med 2002; 195: 781-8.
49. Sternberg EM. Neuroendocrine regulation of autoimmune/inflammatory disease. J Endocrinol 2001; 169: 429-35.
50. Ricci A, Amenta F, Bronzetti E, Mannino F, Marietta S, Tayebati SK. Expression of peripheral blood lymphocyte muscarinic cholinergic receptor subtypes in airway hyperresponsiveness. J Neuroimmunol 2002; 129: 178-85.
51. Fisher JT, Vincent SG, Gomeza J, Yamada M, Wess J. Loss of vagally mediated bradycardia and bronchoconstriction in mice lacking M2 or M3 muscarinic acetylcholine receptors. FASEB J 2004; 18: 711-3.
52. 3 receptors mediate contraction of human central and peripheral airway smooth muscle. Pulm Pharmacol 1990; 3: 47-51.
53. Eglen RM, Hegde SS, Watson N. Muscarinic receptor subtypes and smooth muscle function. Pharmacol Rev 1996; 48:531-65.
54. 3 muscarinic receptors in smooth muscle. Receptors Channels 2003; 9: 261-77.
55. 3 muscarinic acetylcholine receptor regulation in the airway. Am J Respir Cell Mol Biol 2002; 26: 269-72.
56. Lanzafame AA, Christopoulos A, Mitchelson F. Cellular signaling mechanisms for muscarinic acetylcholine receptors. Receptors Channels 2003; 9: 241-60.
57. Somlyo AP, Somlyo AV. Signal transduction by G-proteins, rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II. J Physiol 2000; 552: 177-85.
58. Cohen J, Burggraaf J, Schoemaker R, Sterk PJ, Cohen AF, Diamant Z. Bronchial responsiveness to neurokinin and its relationship to methacholine in asthma. Am J Respir Crit Care Med 2004; 169: A26.
59. q signaling. J Physiol Lung Cell Mol Physiol 2003; 285: L114-20.
60. Townley RG, Bewtra AK, Nair NH, Brodkey FD, Watt GD, Burke KM. Methacholine inhalation challenge studies. J Allergy Clin Immunol 1979; 64: 569-74.
61. Townley RG, Dennis M, Itkin JM. Comparative action of acetyl-beta-methacholine, histamine and pollen antigens in subjects with hay fever and patients with bronchial asthma. J Allergy 1965; 36: 121-37.
62. Townley RG, McGeady S, Bewtra A. The effect of beta adrenergic blockade on bronchial sensitivity to acetyl-beta-choline in normal and allergic rhinitis subjects. J Allergy Clin Immunol 1976; 57: 358-66.
63. Townley RG, Horiba M. Airway hyperresponsiveness. Clin Rev Allergy Immunol 2003; 24: 85-109.
64. Minette PA, Lammers JW, Dixon CM, McCusker ATA, Barnes PJ. A muscarinic agonist inhibits reflex bronchoconstriction in normal human but not in asthmatic subjects. J Appl Physiol 1989; 67: 2461-5.
65. 2 receptor. J Clin Invest 1993; 91: 1314-8.
66. 2 muscarinic receptor function in asthma and animal models of hyperreactivity. Thorax 1998; 53: 613-6.
67. Ihre E, Larsson K. Airways responses to ipratropium bromide do not vary with time in asthmatic subjects. Studies of interindividual and intraindividual variation of bronchodilation and protection against histamine-induced bronchoconstnction. Chest 1990; 97: 46-51.
68. 3 receptor genes in normal and asthmatic subjects. Br J Pharmacol 2001; 133: 43-8.
69. van Schayck CP, Dompeling E, van Herwaarden CL, Folgering H, Verbeek AL, van der Hoogen HJ, et al. Bronchodilator treatment in moderate asthma or chronic bronchitis: continuous or on demand? A randomised controlled study. BMJ 1991; 303: 1426-31.
70. Emala CW, Clancy J, Hirshman CA. Glucocorticoid treatment decreases muscarinic receptor expression in canine airway smooth muscle. Am J Physiol 1997; 272: L745-51.
71. Lombardi MS, Kavelaars A, Heijnen CJ. Role and modulation of G protein-coupled receptor signaling in inflammatory processes. Crit Rev Immunol 2002; 22: 141-63.
72. van Koppen CJ. Multiple pathways for the dynamin-regulated internalization of muscarinic acetylcholine receptors. Biochem Soc Transact 2001; 29: 505-8.
73. Zaagsma J, Roffel AF, Meurs H. Muscarinic control of airway function. Life Sci 1997; 60: 1061-8.
74. Fryer AD, Jacoby DB. Muscarinic receptors and control of airway smooth muscle. Am J Respir Crit Care Med 1998; 158: S154-60.
75. 2 muscarinic receptor dysfunction. J Appl Physiol 2002; 92: 1417-22.
76. Rana BK, Shiina T, Insel PA. Genetic variations and polymorphisms of G protein-coupled receptors: Functional and therapeutic implications. Annu Rev Pharmacol Toxicol 2001; 41: 593-624.
77. Pyne NJ, Rodger IW. Guanine nucleotide binding regulatory protein and receptor-mediated actions. In: Chung KF, Barnes PI, editors. Pliarmacology of the Respiratory Tract. New York: Marcel Dekker; 1993. p. 49-61.
78. Liggett SB. Pharmacogenetics of beta-1- and beta-2-adrenergic receptors. Pharmacology 2000; 61: 167-73.
79. Erickson RP, Graves PE. Genetic variation in β-adrenergic receptors and their relationship to susceptibility for asthma and therapeutic response. Drug Metab Dispos 2001; 29: 557-61.
80. Small KM, McGraw DW, Liggett SB. Pharmacology and physiology of human adrenergic receptor polymorphisms. Annu Rev Pharmacol Toxicol 2003; 43: 381-411.
81. 2-adrenergic receptors: Relevance to asthma. J Allergy Clin Immunol 2000; 105: S487-92.
82. Bai TR, Mark JCW, Barnes PJ. A comparison of β-adrenergic receptors and in vitro relaxant responses to isoproterenol in asthmatic airway smooth muscle. Am J Respir Cell Mol Biol 1992; 6: 647-51.
83. Ploy-Song-Sand Y, Corbin RP, Engel LA. Effects of intravenous histamine on lung mechanics in man after beta-blockade. J Appl Physiol 1978; 44: 690-5.
84. Ryo UY, Townley RG. Comparison of respiratory and cardiovascular effects of isoproterenol, propranolol, and practolol in asthmatic and normal subjects. J Allergy Clin Immunol 1976; 57: 12-24.
85. Orehek J. Gayrard P, Grimaud C, Charpin J. Effect of maximal respiratory manoeuvres on bronchial sensitivity of asthmatic patients as compared to normal people. Br Med J 1975; 1: 123-5.
86. Grieco MH, Pierson RN. Mechanism of bronchoconstriction due to beta-adrenergic blockade. J Allergy 1971; 48: 143-52.
87. Malo JL, Chan-Yeung M. Occupational asthma. J Allergy Clin Immunol 2001; 108: 317-28.
88. Ernst P. Pesticide exposure and asthma. Am J Respir Crit Care Med 2002; 165: 563-4.
89. Ernst P, Cormier Y. Relative scarcity of asthma and atopy among rural adolescents raised on a farm. Am J Respir Crit Care Med 2000; 161: 1563-66.
90. Leynaert B, Neukirch C, Jarvis D, Chinn D, Burney P, Neukirch F. Does living on a farm during childhood protect against asthma, allergic rhinitis, and atopy in adulthood? Am J Respir Crit Care Med 2001; 164: 1829-34.
91. Fryer AD, Lein PJ, Howard AS, Yest BL, Beckles RA, Jett DA. Mechanisms of organophosphate insecticide-induced airway hyperreactivity. Am J Physiol Lung Cell Mol Physiol 2004; 286: L963-9.
92. Dang W, Gilmour MI, Lambert AL, Selgrade MK. Enhanced allergic responses to house dust mite by oral exposure to carbaryl in rats. Toxicol Sci 1998; 44: 63-9.
93. Pope CN. Organophosphorus pesticides: do they all have the same mechanism of toxicity? J Toxicol Environ Health 1999; 2: 161-81.
94. 2 muscarinic receptor by chlorpyrifos oxon in vitro. Toxicol Lett 2001; 119: 21-6.